Bruno Pirovino-zürcher

Executive Director / Board Member (60% mandate)

Unterägeri, Schweiz

Erfahrungen

Jan. 2022 - Bis heute
2 Jahren 6 Monaten
Schweiz

Executive Director / Board Member (60% mandate)

Mitrelli Group (Global Headquarter)

  • Large scale tech infrastructure projects in EMEA.
Jan. 2015 - Dez. 2022
7 Jahren
Zug, Schweiz

Director, Swiss Branch

DalCor Pharmaceuticals

  • Establish and manage a clinical trial in 32 countries. Foster close relationships with venture capitalists and board members - Rounds of financing (Series A, B, and C). Steer efforts in procurement, information technology, and compliance. Manage legal/contractual matters, as well as risk management, including insurance programs.
  • Set up Swiss operations & managed clinical trials (Phase II + III), performed several financing rounds (series A, B and C – total of 290M$), preparing the company for its exit, align due diligence processes, etc. by serving as global sponsor of phase II and III Clinical Trials in Precision medicine.
  • Developed and led business, drug supply and finance processes, incl. stakeholder management, people development, interaction with investors, management reporting, quarterly forecasting, budgeting, strategic long-range planning.
Jan. 2013 - Dez. 2015
3 Jahren
Zug, Schweiz

Business Services Director

Johnson & Johnson (Cilag International)

  • Delivered exceptional support with the integration of new J&J enterprises at the Zug headquarters. Establish and enhance business procedures and the exchange of best practices. Achieved desired goals by developing and leading cross-functional/cross-divisional projects, post-M&A integrations. Create, lead and implemented corporate programs such as Risk Management and Business Continuity Planning, Compliance, Data Privacy, Corporate Social Responsibility (CSR), Environment Health and Safety (EH&S) and Diversity&Inclusion.
  • Attained targeted goals by integrating Consumer Health, Pharma- and Medtech-business leading to synergies with double-digit savings.
  • Introduced Johnson & Johnson in Swiss Networks & Governments (e.g. American-Swiss Chamber of Commerce, Economic Promotion, Tax authorities).
Jan. 2005 - Dez. 2011
6 Jahren
Zürich, Schweiz

Managing Director / Finance Director

Eisai Pharma AG

  • Established Swiss commercial affiliate of a leading Japanese pharmaceutical company. Lead & develop strong business organisation, including Finance / Reporting / MIS / Performance Management, internal and external Audits & tax representation vis-à-vis Swiss tax authorities, Supply Chain/Risk management, Local Compliance Officer/Data Privacy, legal/contract management and strategic/mid-/short-term planning for existing and launch products. Drove pan-European collaboration within Eisai-group (focus: D-A-CH region). Served as business partner for local BD initiatives such as in-licensing, partnering, and launches). Foster collaboration between office- and field-based staff (e.g. joint calls). Rendered expertise in talent development, corporate social responsibility programs, and change and sales force effectiveness programs.
  • Successfully acquired and developed strategic product portfolio.
  • Effectively sustainable turnaround within nine months due to double-digit sales growth and cost-containments.
  • Incorporated as the No. 1 affiliate in the European corporate compliance program.
  • Stellar launch of new oncology franchise, best throughout Eisai Group in Europe
Jan. 1994 - Bis heute
30 Jahren 6 Monaten
Zug, Schweiz

Owner / Managing Director & Interim Manager

Finconor gmbh

  • Board member, Interim CFO, strategic advisor to mature and ScaleUp organisations – managing international expansions in Europe and Africa. Driving excellence programs as Executive Director with focus on optimizing finance processes.
  • Senior leadership roles in turnaround and restructuring situations; Expert at Innosuisse
  • Drove Interim-management in senior financial positions (CFO/Finance Director/Group Controller) as well as finance and supply chain project management. Established and optimised procurement efforts - In/Out-Licensing in the pharmaceutical industry (RX/OTC).
  • Steered efforts in numerous projects in finance and real estate as well as strategy development in supply chain. Built group international controlling ni a publicly-traded corporation ni cl. M&A activities. Integrated group-wide financial planning and reporting software (Hyperion). Ensured compliance with Swiss stock-exchange regulations/security regulatory agencies.
  • Business development in LifeScience / Healthcare
  • Expert at Innosuisse (Federal Swiss Innovation Agency, strengthening competitiveness of Swiss companies with funding instruments). As expert I assess submitted business plans / grant application and advise both Innosuisse as well as Start/ ScaleUps.
Südafrika

Financial Controller

Bakels South Africa (PTY) LTD

  • 2-years’ project
Schweiz

Finance roles with increasing responsibilities

Colt International (Schweiz) AG

Schweiz

Finance Manager (Switzerland)

IMS Information Medical Statistics AG

Project Manager (International)

IMS-Health Group

Finance roles with increasing responsibilities

Perkin-Elmer

Head of Finance/Accounting Central Eastern Europe (CEE)

Pliva International AG

Zusammenfassung

Board Member with extensive global experience in LifeScience/Healthcare directing all business aspects to attain the company’s long-term success and profitability within customer-centric environments. Seasoned leader with expertise in business/finance strategy, formulating innovative and effective plans to foster growth and achieve consistent growth. Proven leader with strategic and tactical decision-making and people leadership to drive revenue growth. Demonstrated expertise in capturing market-leading product positioning, exceeding sales targets, and providing exceptional team leadership for seamless fulfilment of corporate objectives. Track record of prioritising, spearheading, and driving complex transformational projects from conception to completion within agreed timelines and budgetary constraints. Adept at analysing, collating, and interpreting specified requirements into customised deliverables at the highest quality. Skilled in collaborating closely with key stakeholders to develop budget-sensitive, customer-centric, and goal-oriented targeted business and sales strategies for thriving within fast-paced organisations. Board Member, Angel investor and Accelerator Expert @ Innosuisse

  • Board Excellence / Corp.Governance
  • M&A activities & integrations
  • Risk Management
  • Finance Strategy + Management
  • Fundraising / IPO readiness
  • Supply Chain Management
  • People empowerment / enablement
  • Go-to-Market strategies
  • Performance Management
  • Business Growth & Development
  • Process Improvement Initiatives
  • P&L Responsibility

Sprachen

Deutsch
Muttersprache
Englisch
Verhandlungssicher
Französisch
Fortgeschritten
Afrikaans
Grundkenntnisse
Italienisch
Grundkenntnisse
...und 1 Weitere

Ausbildung

Lucerne University of Applied Sciences and Arts

Executive Master of Corporate Finance · Corporate Finance · Schweiz

Lucerne University of Applied Sciences and Arts

Graduate Diploma in Business Administration · Business Administration · Schweiz

Guglielmo Marconi University; CIQ; CMI; Eaton Business School

Executive Master of Business Administration · Business Administration

Zertifikate & Bescheinigungen

Global Social Entrepreneurship Program (CAS)

University of Basel, Switzerland

International Board Certificate Program (BoD CAS)

Swiss Board Institute; University of St. Gallen; Université de Lausanne

Project Management - IPMA Certification

VZPM, Zurich, Switzerland